Pfizer Investigational Site — Bay City, Michigan

Pfizer Investigational Site is a clinical research site located in Bay City, Michigan, United States 48706.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 2 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2, Obesity.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bay City

Browse all research sites in Michigan · View every site in Bay City

• McLaren Bay Region Hospital
• Michigan State University/Bay Regional Medical Center
• Great Lakes Research Group
• McLaren Cancer Institute-Bay City
• Bay Regional Medical Center
• Research Site
• McLaren-Bay Region
• GSK Investigational Site
• Karmanos Cancer Institute at McLaren Bay Region
• Clinical Trial Site
• Dermavant Investigative Site
• McLaren Bay

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 2 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Obesity.

Is Pfizer Investigational Site accredited by Crixeo Clinical Trials?

Pfizer Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.